Sands Capital Life Sciences Pulse Fund II, L.P.

CIK 1875620 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sands Capital Life Sciences Pulse Fund II, L.P..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G/A0001875620-26-000017
Aug 13, 2026SCHEDULE 13G/A0001875620-26-000015
Jul 7, 2026SCHEDULE 13D/A0001875620-26-000010
Apr 23, 2026SCHEDULE 13D0001875620-26-000007
Feb 13, 2026SCHEDULE 13G/A0001875620-26-000002
Nov 24, 202540001875620-25-000025
Aug 13, 2025SCHEDULE 13G/A0001875620-25-000021
Aug 13, 2025SCHEDULE 13G/A0001875620-25-000022
Aug 13, 2025SCHEDULE 13G/A0001875620-25-000020
Jul 15, 20253/A0001875620-25-000002
Apr 9, 2025SCHEDULE 13G0000904454-25-000219
Oct 25, 2024SC 13G0001193125-24-244251
Oct 25, 202430000950170-24-117493
Jun 22, 2023SC 13D/A0001193125-23-172591
Nov 25, 2022SC 13G0001193125-22-292633
Sep 27, 2021SC 13D0001193125-21-282526
Aug 3, 2021D0001875620-21-000002